— Know what they know.
Not Investment Advice

BLMS OTC

Bloomios, Inc.
1W: +0.0% 1M: +0.0% 3M: +200.0% YTD: +200.0% 1Y: +200.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · $19341 mcap · 42M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$26M +549.1% ▲
5Y CAGR: +447.6%
Total Liabilities
$27M +390.1% ▲
5Y CAGR: +112.5%
Shareholders Equity
-$1M +15.8% ▲
Cash & Investments
$118K -56.5% ▼
5Y CAGR: +86.0%
Total Debt
$22M +776.6% ▲
5Y CAGR: +127.8%
Net Debt
$22M +879.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2006FY2019FY2020FY2021FY2022
— Assets —
Cash$10K$1K$72K$271K-$57K
Short-Term Investments$0$0$50K$0$0
Cash & ST Investments$10K$1K$122K$271K$118K
Net Receivables$0$0$36K$56K$526K
Inventory$0$0$292K$512K$2M
Other Current Assets$0$0$0$0$0
Total Current Assets$10K$1K$451K$2M$2M
Property, Plant & Equip.$0$0$2M$2M$2M
Goodwill & Intangibles$0$0$300K$300K$22M
Long-Term Investments$0$0$0$50K$50K
Other Non-Current Assets$0$0$165K$117K$67K
Total Non-Current Assets$0$0$3M$2M$24M
Total Assets$10K$1K$3M$4M$26M
— Liabilities —
Accounts Payable$85K$0$2M$2M$2M
Short-Term Debt$397K$0$783K$2M$22M
Deferred Revenue$19K$0$150K$240K$437K
Other Current Liabilities$249K$433K$600K$300K$300K
Total Current Liabilities$750K$433K$3M$5M$27M
Long-Term Debt$0$41K$831K$150K$150K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$482K$41K$974K$250K$150K
Total Liabilities$750K$474K$4M$6M$27M
— Equity —
Common Stock$5$125$125$144$284
Retained Earnings-$3M-$3M-$4M-$6M-$20M
Accumulated OCI$0$0$0$62K$4M
Total Stockholders Equity-$739K-$3M-$1M-$2M-$1M
Total Liabilities & Equity$10K$1K$3M$4M$26M
— Key Metrics —
Total Debt$397K$41K$2M$3M$22M
Net Debt$387K$40K$2M$2M$22M
Total Investments$0$0$50K$50K$50K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms